Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Level 4, Clinical Sciences Building, Parkville, VIC, 3050, Australia.
Murdoch Childrens Research Institute, Parkville, VIC, Australia.
Osteoporos Int. 2017 Sep;28(9):2619-2631. doi: 10.1007/s00198-017-4100-6. Epub 2017 Jun 28.
The study aimed to explore determinants of bone parameters in young women. Most bone parameters were associated with height and lean mass. Bone parameters were not associated with vitamin D status. Future research should address whether interventions aimed at improving lean mass are beneficial to bone health in young women.
The implementation of prevention strategies during young adulthood may be crucial for osteoporosis prevention in later life, yet literature examining the determinants of bone health in premenopausal women is limited. We aimed to assess determinants of bone health, including serum 25-hydroxyvitamin D (25OHD), in females aged 16-25 years, living in Victoria, Australia, recruited through Facebook advertising.
Serum 25OHD was measured by liquid chromatography-tandem mass spectrometry and bone health was measured using dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) in 326 participants.
Mean (± standard deviation) serum 25OHD was 69 ± 28 nmol/L and the prevalence of vitamin D deficiency (serum 25OHD <50 nmol/L) was 26%. Seven percent of participants (n = 23) reported taking a vitamin D supplement. Two percent of participants had low lumbar spine bone mineral density (Z-score <-2.0), 5% at the hip and 7% at the femoral neck. Serum 25OHD levels were not associated with DXA bone parameters, nor with pQCT bone parameters. Most bone parameters were positively associated with height and lean mass.
Vitamin D status was not associated with bone health in young women in the current study. Our findings suggest that targeting other modifiable factors, such as lean body mass, is likely to be beneficial to bone health in young women. Longitudinal studies examining the association between vitamin D status and bone health in young women are necessary to confirm our findings. In addition, whether raising 25OHD levels is advantageous for young women's bone health is yet to be determined.
探索年轻女性骨参数的决定因素。大多数骨参数与身高和瘦体重相关。骨参数与维生素 D 状态无关。未来的研究应探讨旨在增加瘦体重的干预措施是否有益于年轻女性的骨骼健康。
在年轻成年期实施预防策略对于预防晚年骨质疏松症可能至关重要,但研究绝经前女性骨骼健康决定因素的文献有限。我们旨在评估骨健康的决定因素,包括血清 25-羟维生素 D(25OHD),在澳大利亚维多利亚州通过 Facebook 广告招募的年龄在 16-25 岁的女性中进行。
通过液相色谱-串联质谱法测量血清 25OHD,通过双能 X 射线吸收法(DXA)和外周定量计算机断层扫描(pQCT)测量 326 名参与者的骨健康。
平均(±标准差)血清 25OHD 为 69±28nmol/L,维生素 D 缺乏症(血清 25OHD <50nmol/L)的患病率为 26%。7%的参与者(n=23)报告服用维生素 D 补充剂。2%的参与者腰椎骨矿物质密度较低(Z 分数 <-2.0),5%的参与者髋部和 7%的参与者股骨颈较低。血清 25OHD 水平与 DXA 骨参数无关,与 pQCT 骨参数也无关。大多数骨参数与身高和瘦体重呈正相关。
在当前研究中,维生素 D 状态与年轻女性的骨骼健康无关。我们的研究结果表明,针对其他可改变的因素(如瘦体重)可能有益于年轻女性的骨骼健康。需要进行纵向研究来检验年轻女性维生素 D 状态与骨骼健康之间的关联,以证实我们的发现。此外,提高 25OHD 水平是否对年轻女性的骨骼健康有益尚待确定。